Home | Welcome to Contract Pharma   
Last Updated Thursday, April 24 2014
Print

SNBL USA Appoints Field Technical Director



Published June 28, 2013
Related Searches: Preclinical Development www.contractpharma.com contractpharma
Michael Templin, Ph.D., DABT, has been named field technical director for SNBL USA.  Dr. Templin, based on the west coast, will work closely with business development and internal scientific teams to provide SNBL USA’s clients with scientific and regulatory guidance to support their preclinical development programs. He joins the company from Marina Biotech where he served as chief technology officer.
 
Dr. Templin is a board-certified toxicologist with more than 15 years of experience in preclinical and early clinical drug development. He has extensive experience in small molecules, biologics, peptides and multiple classes of nucleic acid-based drugs, and has worked in multiple therapeutic areas including cancer, inflammation, cardiovascular, metabolic and antivirals. He also has experience with nonhuman primate programs, including design, oversight and interpretation of research and GLP studies for INDs, NDAs and ex-U.S. submissions.
 
“This is an exciting time for SNBL USA and our clients,” said Mark Crane, vice president of business development. “Dr. Templin’s exceptional preclinical and early clinical background, along with his technical expertise and outstanding communication skills, will significantly enhance the benefits in working with SNBL USA.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On